Instaclop (Clopidogrel) – as a Safe Anti - Platelet Therapy

Simple item page
dc.creatorSharipova Elvina Midatovna
dc.date2024-05-21
dc.date.accessioned2024-10-12T12:36:10Z
dc.date.available2024-10-12T12:36:10Z
dc.descriptionThe article describes the effectiveness and clinical pharmacology of the main class of modern antiplatelet agents used in the clinical practice of a cardiotherapist, intervention cardiologist in the treatment of coronary heart disease and other pathologies of the cardiovascular system. According to the latest studies conducted on the effectiveness of the drug clopidogrel (Instaclop), the main clinical and pharmacological characteristics of the drug Instaclop.en-US
dc.formatapplication/pdf
dc.identifierhttps://journals.proindex.uz/index.php/JSML/article/view/1005
dc.identifier.urihttps://dspace.umsida.ac.id/handle/123456789/37555
dc.languageeng
dc.publisherPro Indexen-US
dc.relationhttps://journals.proindex.uz/index.php/JSML/article/view/1005/846
dc.sourceJournal of Science in Medicine and Life; Vol. 2 No. 5 (2024): Journal of Science in Medicine and Life; 171-177en-US
dc.source2992-9202
dc.subjectantiplatelet therapy, clopidogrel, Instaclop, clinical pharmacology, safety, effectiveness.en-US
dc.titleInstaclop (Clopidogrel) – as a Safe Anti - Platelet Therapyen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files
Collections
Journal of Science in Medicine and Life